1-12 of 12
Sandra B. Horowitz
Close
Sort by
Journal Articles

Primary Analysis of a Pilot Study of Prophylactic Anakinra to Mitigate CAR T Cell-Associated Toxicity in Patients with Relapsed or Refractory Large B-Cell Lymphoma

Paolo Strati, Xubin Li, Qing Deng, Lei Feng, Ryan Sun, Andrew Jallouk, Sherry Adkins, Taylor Cain, Swapna Johncy, Raphael E Steiner, Sairah Ahmed, Dai Chihara, Luis Fayad, Swaminathan Padmanabhan Iyer, Sandra B. Horowitz, Rachel Nehlsen, Loretta J. Nastoupil, Ranjit Nair, Ahmed Hassan, Taher Daoud, Misha Hawkins, Felipe Samaniego, Maria Alma Rodriguez, Elizabeth J Shpall, Partow Kebriaei, Christopher R. Flowers, David Hong, Jason Westin, Sattva S. Neelapu, Michael R. Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 7493–7495.
https://doi.org/10.1182/blood-2022-157448
Published: 2022
Journal Articles

Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response at Time of Infusion

Sushanth Gouni, Jason R. Westin, Haleigh Mistry, Raphael Eric Steiner, Jinsu James, Simrit Parmar, Mansoor Noorani, Nathan H. Fowler, Sandra B. Horowitz, Lei Feng, Luis E. Fayad, Swaminathan P Iyer, Michael R Green, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta Nastoupil, Sattva S. Neelapu, Yago Nieto, Paolo Strati
Journal: Blood
Blood (2021) 138 (Supplement 1): 1740.
https://doi.org/10.1182/blood-2021-145503
Published: 2021
Journal Articles

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

Brief Report
Paolo Strati, Sairah Ahmed, Fateeha Furqan, Luis E. Fayad, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sandra B. Horowitz, Lei Feng, Ryan Sun, Catherine M. Claussen, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J. Shpall, Michael R. Green, Christopher R. Flowers, Jason Westin, Sattva S. Neelapu
Journal: Blood
Blood (2021) 137 (23): 3272–3276.
https://doi.org/10.1182/blood.2020008865
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical Efficacy of Polatuzumab Vedotin in Patients with Relapsed/Refractory Large B-Cell Lymphoma after Standard of Care Axicabtagene Ciloleucel

Paolo Strati, MD, Grace Watson, Sandra B. Horowitz, Pharm.D., Ranjit Nair, MD, Maria Alma Rodriguez, MD, Raphael Eric Steiner, MD, Luis Fayad, Jason R. Westin, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-135835
Published: 2020
Journal Articles

Hyperfractionated Cyclophosphamide-Dexamethasone (HyperCy-Dex) with or without Carfilzomib (Car) in Patients (pts) with Multiple Myeloma (MM)

Erin K. Yeung, Pharm.D., Brian R. Primeaux, Pharm.D., Sandra B. Horowitz, Pharm.D., Brandon R. Shank, Irene Y. Lee, Gregory P. Kaufman, MD, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Donna M. Weber, MD, Sheeba K. Thomas, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-137704
Published: 2020
Journal Articles

Descriptive Analysis of Isatuximab Use Following Prior Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma

Melody R Becnel, MD, Sandra B. Horowitz, Pharm.D., Sheeba K. Thomas, MD, Swami P. Iyer, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Donna M. Weber, MD, Gregory P. Kaufman, MD, Hans C. Lee, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-140526
Published: 2020
Journal Articles

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma

Clinical Trials & Observations
Michelle A. Fanale, Chan Yoon Cheah, Amy Rich, L. Jeffrey Medeiros, Chao-Ming Lai, Yasuhiro Oki, Jorge E. Romaguera, Luis E. Fayad, F. B. Hagemeister, Felipe Samaniego, Maria A. Rodriguez, Sattva S. Neelapu, Hun J. Lee, Loretta Nastoupil, Nathan H. Fowler, Francesco Turturro, Jason R. Westin, Michael L. Wang, Peter McLaughlin, Chelsea C. Pinnix, Sarah A. Milgrom, Bouthaina Dabaja, Sandra B. Horowitz, Anas Younes
Journal: Blood
Blood (2017) 130 (4): 472–477.
https://doi.org/10.1182/blood-2017-02-766121
Published: 2017
Journal Articles

High Response Rate of Romidepsin in Combination with ICE (Ifosfamide, Carboplatin and Etoposide) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: Updates of Phase I Trial

Dai Chihara, MD PhD, Yasuhiro Oki, MD, Jason R Westin, MD, Loretta Nastoupil, MD, Luis E. Fayad, MD, Felipe Samaniego, MD, Emily Wesson, APN, Charnelle Ruben, BS, Sandra B. Horowitz, PharmD, Lei Feng, MS, Naveen Garg, Sairah Ahmed, MD, Issa F. Khouri, Chitra M. Hosing, MD, Jorge E. Romaguera, MD, Nathan Fowler, MD, Michelle A. Fanale, MD
Journal: Blood
Blood (2015) 126 (23): 3987.
https://doi.org/10.1182/blood.V126.23.3987.3987
Published: 2015
Journal Articles

Gene Expression Profiling for Molecular Features of Response in a Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas

Michelle A. Fanale, MD, Zhiqiang Wang, PhD, Wencai Ma, PhD, Yasuhiro Oki, MD, Fredrick B. Hagemeister, MD, Luis E. Fayad, MD, Nathan Fowler, MD, Jorge E. Romaguera, MD, Nina Shah, MD, Hubert H Chuang, MD PhD, Feng Lei, MS, Sandra B. Horowitz, PharmD, Dai Chihara, MD PhD, Emily Wesson, APN, Toni Y Hutto, BS, Charnelle Ruben, BS, Felipe Samaniego, MD, Tariq Muzzafar, MD, Richard Piekarz, PhD MD, R Eric Davis, MD
Journal: Blood
Blood (2015) 126 (23): 2705.
https://doi.org/10.1182/blood.V126.23.2705.2705
Published: 2015
Journal Articles

A Phase I Trial of Alisertib Plus Romidepsin for Relapsed/Refractory Aggressive B- and T-Cell Lymphomas

Michelle A. Fanale, MD, Fredrick B. Hagemeister, MD, Luis Fayad, MD, Yasuhiro Oki, MD, Nathan Fowler, MD, Jorge Romaguera, MD, Nina Shah, Hubert Chuang, MD, Lei Feng, MS, Sandra B Horowitz, PharmD, Emily Wesson, APN, Toni Y Hutto, BS, Tariq Muzzafar, MD, Felipe Samaniego, MD, R Eric Davis, MD
Journal: Blood
Blood (2014) 124 (21): 1744.
https://doi.org/10.1182/blood.V124.21.1744.1744
Published: 2014
Journal Articles

Phase I Study of Romidepsin in Combination with ICE (Ifosfamide, Carboplatin and Etoposide) in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Dai Chihara, MD PhD, Yasuhiro Oki, MD, Luis Fayad, MD, Emily Wesson, APN, Charnelle Ruben, Sandra B Horowitz, PharmD, Joseph Woolery, PharmD, Lei Feng, MS, Naveen Garg, Sairah Ahmed, MD, Issa F. Khouri, MD, Michelle A. Fanale, MD
Journal: Blood
Blood (2014) 124 (21): 1748.
https://doi.org/10.1182/blood.V124.21.1748.1748
Published: 2014
Journal Articles

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Michelle A. Fanale, MD, Chao-Ming Lai, APN, Sue A Rimes, RN, Mildred M Ramirez, MD, Fredrick B Hagemeister, MD, Nathan H Fowler, MD, Anas Younes, MD, Luis E Fayad, MD, Maria Alma Rodriguez, MD, Francesco Turturro, MD, Felipe Samaniego, MD, MPH, Jorge E Romaguera, MD, Victor A Levin, MD, Sandra B Horowitz, PharmD, Joseph E Woolery, PharmD, Andrea Milbourne, MD
Journal: Blood
Blood (2012) 120 (21): 3670.
https://doi.org/10.1182/blood.V120.21.3670.3670
Published: 2012